Pharma & Life Sciences

Commercial intelligence
that cites its source.

Aqlyx unifies IQVIA, Veeva, field engagement, and sales data into one governed intelligence layer. Ask any question about NRx, market share, or rep performance and get a verified answer in seconds.

Request a demoExplore Retail solution
6+
Disconnected data sources
IQVIA, Veeva, field CRM, sales systems, and market access data all live in separate silos. Answering one commercial question takes days of manual pulling.
72h
Average reporting lag
By the time a territory report reaches the field or brand team, the data is three days old. Decisions are made on yesterday's picture.
0
Questions answered in real time
No current BI tool lets a brand manager ask "which territories are underperforming on NRx vs. target this week?" and get a reliable answer instantly.
Data sources
Works with your pharma data stack

Connect industry-standard and proprietary sources. Aqlyx ingests, normalizes, and pre-computes commercial metrics automatically. No data exports. No SQL required.

IQVIA (NRx, TRx, Market Share)
Veeva CRM
Veeva Link (KOL & HCP data)
Field Engagement Activity
Sales & Revenue (ERP / SAP)
Prescription & Claims Data
Market Access / Formulary Data
Social Media (HCP Channels)
+ your custom source
Live example answers
Questions your commercial team asks every week

Real question types Aqlyx answers in seconds. Every figure retrieved from pre-validated data sources, never estimated by the AI.

What is our market share in the cardiovascular segment this quarter versus last quarter? How do we compare to the top competitor?

Your cardiovascular market share for Q2 2026 is 14.3%, up from 12.8% in Q1 — a gain of +1.5 percentage points.

Top competitor holds 31.2%, down 0.4pp this quarter. The gap is narrowing.

Your share gain is strongest in the Northeast (+2.1pp) and Central regions (+1.8pp). Pacific remains flat at 10.2%.

Source: IQVIA market share dataset
What is the NRx trend for our lead product over the last 6 weeks by territory? Which territories are growing and which are declining?

NRx over the last 6 weeks: national growth of +11%.

Growing: Northeast +19% · Central +14% · Mid-Atlantic +9%
Flat: Southeast +1% · Mountain +2%
Declining: Pacific -3% · Gulf Coast -5%

Gulf Coast is the sharpest decline — field call data shows 22% fewer HCP visits in this territory vs. the prior 6-week period. Likely correlated.

Source: IQVIA prescription data · Field engagement activity
Which field reps exceeded their HCP call targets last month and which territories are underperforming? Show me the bottom 5.

In June 2026, 8 of 24 reps exceeded their HCP call target.

Top performer: Northeast Region — 134% of target, 91 calls logged.

Bottom 5 territories by attainment:
Gulf Coast · 58% · 39 of 67 calls
Pacific North · 61% · 41 of 67 calls
Southwest · 64% · 43 of 67 calls
Mountain · 67% · 45 of 67 calls
Southeast B · 69% · 46 of 67 calls

All 5 underperforming territories also show flat or declining NRx this month.

Source: Veeva CRM · Field engagement activity
Which KOL events and congresses generated the most measurable NRx lift in Q2? How many HCPs attended and what was the 30-day script impact?

Three events drove measurable NRx lift within 30 days in Q2:

ACC 2026 — 214 HCPs attended · +340 NRx lift in 30 days · highest ROI event
AHA Regional Summit — 87 HCPs · +210 NRx lift · strong cardiologist segment
Regional Cardiology Symposium — 44 HCPs · +88 NRx · cost-efficient for scale

Two events showed no measurable lift. Aqlyx cross-referenced Veeva event attendance lists with IQVIA prescription data at the HCP level.

Source: Veeva Link · IQVIA prescription data (HCP-level linkage)
Use cases
Everything your commercial team needs to know

Pre-built analytics coverage across the full pharma commercial operation.

📈
Market Share & NRx Tracking
Weekly NRx and TRx trends by product, segment, and territory. Market share versus named competitors. Powered by IQVIA datasets.
🗺️
Territory & Rep Performance
HCP call attainment, visit frequency, and NRx correlation by territory and rep. Identify underperforming territories before they show up in quarterly reviews.
💊
Formulary & Market Access
Formulary coverage by payer and geography. Track access restrictions that correlate with NRx suppression in specific territories.
🎤
KOL Engagement & Event ROI
Link Veeva event attendance to IQVIA prescription data at the HCP level. Measure which congresses and KOL programs drive measurable script lift.
🏥
HCP Profiling & Segmentation
Segment HCPs by prescribing volume, specialty, territory, and engagement history. Prioritize outreach based on data, not intuition.
📱
Digital & Social Signals
HCP engagement with digital channels, conference social activity, and competitor share-of-voice. Connect online signals to offline prescription behavior.
Why it works for pharma
Built on a governed data foundation
🔒
No hallucinated numbers
The AI agent never calculates live. It only retrieves pre-validated metrics from a governed layer. Every NRx figure, market share, or call count is sourced and auditable.
🏗️
Medallion architecture
Raw data from IQVIA and Veeva flows through Bronze, Silver, Gold, and Platinum layers. Each layer validates, normalizes, and enriches before the AI ever touches it.
🏢
Isolated per client
Each pharma client gets a fully isolated deployment. No shared data, no shared infrastructure. Your commercial data never touches another tenant's environment.

Your commercial data knows
things your team doesn't.

Ask Aqlyx. Get a verified answer with the source cited, in seconds.

Request a demoExplore Retail solution →